The treatment however significantly reduced the number of Aβ plaques in the subiculum of AD mice (p < 0.05, Fig. 4E, F), but did not affect the number of large (>50 μm2) Iba1+ microglial cells in the hippocampus (Supplementary Fig. 5C). Here, AIF1 is linked to Alzheimer disease.